JOANNA MOHNEY: Open Payments
NPI 1043814411 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$572 in 24 payments from 15 companies in 2025. Trend: 2023 $151 · 2024 $420 · 2025 $572
Food & beverage: $572
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $133 |
| Novartis Pharmaceuticals Corporation | 4 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Novocure Inc. | 2 | $41 |
| Astellas Pharma US Inc | 2 | $40 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| TerSera Therapeutics LLC | 2 | $38 |
| ABBVIE INC. | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $21 |
Products named: Stivarga, Optune Lua (NovoTTF-200T), Vyloy, LUTATHERA, LIBTAYO, Tecentriq, Xermelo, Zoladex.
Industry payments across NJ — which companies pay providers there.
